Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
12,5 USD | +1,87% | +5,04% | +40,45% |
26/04 | HIMS & HERS HEALTH, INC. : giudizio positivo da Seaport Global Securities | ZM |
16/04 | HIMS & HERS HEALTH, INC. : downgrade a Neutral da Jefferies & Co. | ZM |
Attività
Numero di dipendenti: 1 046
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 35 | 20/01/21 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 57 | 24/01/22 |
Patrick Carroll
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/01/19 |
Melissa Baird
COO | Chief Operating Officer | 46 | 20/01/21 |
Daniel Lieberman
PRN | Corporate Officer/Principal | - | 14/03/23 |
Irene Becklund
AUD | Comptroller/Controller/Auditor | 40 | - |
Mike Chi
SAM | Sales & Marketing | 44 | 01/04/21 |
Soleil Boughton
LAW | General Counsel | 45 | 20/01/21 |
Scott J. Knoer
PRN | Corporate Officer/Principal | - | 05/12/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Delos Cosgrove
BRD | Director/Board Member | 82 | 20/01/21 |
Director/Board Member | 41 | 01/10/17 | |
Alex Bard
BRD | Director/Board Member | 49 | 20/01/21 |
David Wells
BRD | Director/Board Member | 52 | 20/01/21 |
Director/Board Member | 46 | 01/11/20 | |
Andrew Dudum
CEO | Chief Executive Officer | 35 | 20/01/21 |
Patrick Carroll
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/01/19 |
Andrea Perez
BRD | Director/Board Member | 43 | 05/03/21 |
Director/Board Member | 53 | 16/02/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 8 377 623 | 0 | 0 | 83,01 % |
Azione B | 1 | 205 872 690 | 177 839 553 ( 86,38 %) | 0 |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+40,45% | 2,68 Mrd | |
+22,83% | 527 Mln | |
+42,77% | 467 Mln | |
-64,56% | 156 Mln | |
-31,65% | 85,12 Mln |
- Borsa valori
- Azioni
- Azione HIMS
- Società Hims & Hers Health, Inc.